Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by BigShoes13on Apr 30, 2015 12:55am

85 Views

Post# 23679207

RE:RE:RE:RE:RE:RE:RE:y and when

hahaha.... I guess I could have stayed her for the last two years and always tell myself "look at the recent trading, wow that's a sign this is about to blast off. Boy this is a great company, I'm going to be rich." No unfortunately you will be dead before that happens... but you will continue to lie to yourself as it makes you feel good.... good luck in the poor house buddy

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading